Literature DB >> 17439428

Progenitor cells and adult neurogenesis in neurodegenerative diseases and injuries of the basal ganglia.

Maurice A Curtis1, Peter S Eriksson, Richard L M Faull.   

Abstract

1. The subventricular zone (SVZ) of the forebrain that overlies the caudate nucleus is one of the principal brain regions in which neurogenesis occurs in the human brain, throughout life. 2. In response to the degeneration that occurs in the caudate nucleus in Huntington's disease, or in the caudate nucleus or cortex in stroke models, the SVZ increases the production of progenitor cells that migrate towards the site of the damage where they can differentiate into mature neurons and glial cells. The SVZ contains three main cell types and these are progenitor cells, glial cells and migratory neuroblasts; glial cells are the most common cell type and, in response to Huntington's disease, most of the SVZ cell proliferation is glial, but the number of precursor and neuroblasts is also increased. 3. The SVZ is enriched in neuroactive compounds, such as neuropeptide Y and gamma-aminobutyric acid receptor subunits gamma2, which stimulate ongoing neurogenesis. Interestingly, these stimulating cues are upregulated in the SVZ in response to Huntington's disease. Thus, the SVZ comprises heterogeneous cell types that are maintained in an environment that is permissive to neurogenesis and gliogenesis, and responds to neurodegenerative changes in adjacent brain regions by increasing progenitor cell proliferation and neurogenesis in an attempt to replace the cells that die as a result of neurodegeneration.

Entities:  

Mesh:

Year:  2007        PMID: 17439428     DOI: 10.1111/j.1440-1681.2007.04609.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  38 in total

1.  Increased Olfactory Bulb BDNF Expression Does Not Rescue Deficits in Olfactory Neurogenesis in the Huntington's Disease R6/2 Mouse.

Authors:  Shamayra Smail; Dalbir Bahga; Brittnee McDole; Kathleen Guthrie
Journal:  Chem Senses       Date:  2016-01-18       Impact factor: 3.160

Review 2.  Ischemic stroke and neurogenesis in the subventricular zone.

Authors:  Rui Lan Zhang; Zheng Gang Zhang; Michael Chopp
Journal:  Neuropharmacology       Date:  2008-06-03       Impact factor: 5.250

3.  Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease.

Authors:  Wenzhen Duan; Qi Peng; Naoki Masuda; Eric Ford; Erik Tryggestad; Bruce Ladenheim; Ming Zhao; Jean Lud Cadet; John Wong; Christopher A Ross
Journal:  Neurobiol Dis       Date:  2008-03-10       Impact factor: 5.996

4.  Association of age at onset in Huntington disease with functional promoter variations in NPY and NPY2R.

Authors:  Eugen Kloster; Carsten Saft; Denis A Akkad; Jörg T Epplen; Larissa Arning
Journal:  J Mol Med (Berl)       Date:  2014-02       Impact factor: 4.599

5.  Dopaminergic innervation of the human subventricular zone: a comparison between Huntington's chorea and Parkinson's disease.

Authors:  Martin Parent; C Bédard; E Pourcher
Journal:  Am J Neurodegener Dis       Date:  2013-09-18

Review 6.  The subependymal zone neurogenic niche: a beating heart in the centre of the brain: how plastic is adult neurogenesis? Opportunities for therapy and questions to be addressed.

Authors:  Ilias Kazanis
Journal:  Brain       Date:  2009-09-22       Impact factor: 13.501

7.  Where will the next generation of stroke treatments come from?

Authors:  D W Howells; G A Donnan
Journal:  PLoS Med       Date:  2010-03-02       Impact factor: 11.069

8.  Neuronal and cognitive plasticity: a neurocognitive framework for ameliorating cognitive aging.

Authors:  Pamela M Greenwood; Raja Parasuraman
Journal:  Front Aging Neurosci       Date:  2010-11-29       Impact factor: 5.750

Review 9.  The role of dopamine in Huntington's disease.

Authors:  Carlos Cepeda; Kerry P S Murphy; Martin Parent; Michael S Levine
Journal:  Prog Brain Res       Date:  2014       Impact factor: 2.453

10.  Adult neural stem cells: The promise of the future.

Authors:  Philippe Taupin
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.